Cangene's 61,000ft² biopharmaceutical facility is designed for the manufacture of recombinant proteins up to 2,100L working volume.
This image is to illustrate the Cangene company profile. From here you can view the profile or send an enquiry.
Copyright 2007SPG Media Limited a subsidiary of SPG Media Group PLC
